Ligand Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
Amgen USD 538M 33.04B 2025-06
Arrowhead Research USD 138.14M 137.91M 2025-06
Baxter International USD 683M 0 2024-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
Insmed USD 211.11M 209.29M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Ligand Pharmaceuticals USD 19.41M 19.39M 2025-06
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Pacira USD 44.9M 44.85M 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Veracyte USD 78.32M 78.24M 2025-06


Ligand Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.